265 related articles for article (PubMed ID: 34520569)
1. A transcriptome-wide association study identifies novel candidate susceptibility genes for prostate cancer risk.
Liu D; Zhu J; Zhou D; Nikas EG; Mitanis NT; Sun Y; Wu C; Mancuso N; Cox NJ; Wang L; Freedland SJ; Haiman CA; Gamazon ER; Nikas JB; Wu L
Int J Cancer; 2022 Jan; 150(1):80-90. PubMed ID: 34520569
[TBL] [Abstract][Full Text] [Related]
2. Identification of Novel Susceptibility Loci and Genes for Prostate Cancer Risk: A Transcriptome-Wide Association Study in Over 140,000 European Descendants.
Wu L; Wang J; Cai Q; Cavazos TB; Emami NC; Long J; Shu XO; Lu Y; Guo X; Bauer JA; Pasaniuc B; Penney KL; Freedman ML; Kote-Jarai Z; Witte JS; Haiman CA; Eeles RA; Zheng W;
Cancer Res; 2019 Jul; 79(13):3192-3204. PubMed ID: 31101764
[TBL] [Abstract][Full Text] [Related]
3. Transcriptome-Wide Association Study Identifies New Candidate Susceptibility Genes for Glioma.
Atkins I; Kinnersley B; Ostrom QT; Labreche K; Il'yasova D; Armstrong GN; Eckel-Passow JE; Schoemaker MJ; Nöthen MM; Barnholtz-Sloan JS; Swerdlow AJ; Simon M; Rajaraman P; Chanock SJ; Shildkraut J; Bernstein JL; Hoffmann P; Jöckel KH; Lai RK; Claus EB; Olson SH; Johansen C; Wrensch MR; Melin B; Jenkins RB; Sanson M; Bondy ML; Houlston RS
Cancer Res; 2019 Apr; 79(8):2065-2071. PubMed ID: 30709929
[TBL] [Abstract][Full Text] [Related]
4. An integrative multi-omics analysis to identify candidate DNA methylation biomarkers related to prostate cancer risk.
Wu L; Yang Y; Guo X; Shu XO; Cai Q; Shu X; Li B; Tao R; Wu C; Nikas JB; Sun Y; Zhu J; Roobol MJ; Giles GG; Brenner H; John EM; Clements J; Grindedal EM; Park JY; Stanford JL; Kote-Jarai Z; Haiman CA; Eeles RA; Zheng W; Long J; ; ; ; ;
Nat Commun; 2020 Aug; 11(1):3905. PubMed ID: 32764609
[TBL] [Abstract][Full Text] [Related]
5. A Transcriptome-Wide Association Study Identifies Candidate Susceptibility Genes for Pancreatic Cancer Risk.
Liu D; Zhou D; Sun Y; Zhu J; Ghoneim D; Wu C; Yao Q; Gamazon ER; Cox NJ; Wu L
Cancer Res; 2020 Oct; 80(20):4346-4354. PubMed ID: 32907841
[TBL] [Abstract][Full Text] [Related]
6. DNA methylation and cis-regulation of gene expression by prostate cancer risk SNPs.
Dai JY; Wang X; Wang B; Sun W; Jordahl KM; Kolb S; Nyame YA; Wright JL; Ostrander EA; Feng Z; Stanford JL
PLoS Genet; 2020 Mar; 16(3):e1008667. PubMed ID: 32226005
[TBL] [Abstract][Full Text] [Related]
7. A joint transcriptome-wide association study across multiple tissues identifies candidate breast cancer susceptibility genes.
Gao G; Fiorica PN; McClellan J; Barbeira AN; Li JL; Olopade OI; Im HK; Huo D
Am J Hum Genet; 2023 Jun; 110(6):950-962. PubMed ID: 37164006
[TBL] [Abstract][Full Text] [Related]
8. Multi-ethnic transcriptome-wide association study of prostate cancer.
Fiorica PN; Schubert R; Morris JD; Abdul Sami M; Wheeler HE
PLoS One; 2020; 15(9):e0236209. PubMed ID: 32986714
[TBL] [Abstract][Full Text] [Related]
9. A Transcriptome-Wide Association Study Identifies Novel Candidate Susceptibility Genes for Pancreatic Cancer.
Zhong J; Jermusyk A; Wu L; Hoskins JW; Collins I; Mocci E; Zhang M; Song L; Chung CC; Zhang T; Xiao W; Albanes D; Andreotti G; Arslan AA; Babic A; Bamlet WR; Beane-Freeman L; Berndt S; Borgida A; Bracci PM; Brais L; Brennan P; Bueno-de-Mesquita B; Buring J; Canzian F; Childs EJ; Cotterchio M; Du M; Duell EJ; Fuchs C; Gallinger S; Gaziano JM; Giles GG; Giovannucci E; Goggins M; Goodman GE; Goodman PJ; Haiman C; Hartge P; Hasan M; Helzlsouer KJ; Holly EA; Klein EA; Kogevinas M; Kurtz RJ; LeMarchand L; Malats N; Männistö S; Milne R; Neale RE; Ng K; Obazee O; Oberg AL; Orlow I; Patel AV; Peters U; Porta M; Rothman N; Scelo G; Sesso HD; Severi G; Sieri S; Silverman D; Sund M; Tjønneland A; Thornquist MD; Tobias GS; Trichopoulou A; Van Den Eeden SK; Visvanathan K; Wactawski-Wende J; Wentzensen N; White E; Yu H; Yuan C; Zeleniuch-Jacquotte A; Hoover R; Brown K; Kooperberg C; Risch HA; Jacobs EJ; Li D; Yu K; Shu XO; Chanock SJ; Wolpin BM; Stolzenberg-Solomon RZ; Chatterjee N; Klein AP; Smith JP; Kraft P; Shi J; Petersen GM; Zheng W; Amundadottir LT
J Natl Cancer Inst; 2020 Oct; 112(10):1003-1012. PubMed ID: 31917448
[TBL] [Abstract][Full Text] [Related]
10. Identifying Novel Susceptibility Genes for Colorectal Cancer Risk From a Transcriptome-Wide Association Study of 125,478 Subjects.
Guo X; Lin W; Wen W; Huyghe J; Bien S; Cai Q; Harrison T; Chen Z; Qu C; Bao J; Long J; Yuan Y; Wang F; Bai M; Abecasis GR; Albanes D; Berndt SI; Bézieau S; Bishop DT; Brenner H; Buch S; Burnett-Hartman A; Campbell PT; Castellví-Bel S; Chan AT; Chang-Claude J; Chanock SJ; Cho SH; Conti DV; Chapelle A; Feskens EJM; Gallinger SJ; Giles GG; Goodman PJ; Gsur A; Guinter M; Gunter MJ; Hampe J; Hampel H; Hayes RB; Hoffmeister M; Kampman E; Kang HM; Keku TO; Kim HR; Le Marchand L; Lee SC; Li CI; Li L; Lindblom A; Lindor N; Milne RL; Moreno V; Murphy N; Newcomb PA; Nickerson DA; Offit K; Pearlman R; Pharoah PDP; Platz EA; Potter JD; Rennert G; Sakoda LC; Schafmayer C; Schmit SL; Schoen RE; Schumacher FR; Slattery ML; Su YR; Tangen CM; Ulrich CM; van Duijnhoven FJB; Van Guelpen B; Visvanathan K; Vodicka P; Vodickova L; Vymetalkova V; Wang X; White E; Wolk A; Woods MO; Casey G; Hsu L; Jenkins MA; Gruber SB; Peters U; Zheng W
Gastroenterology; 2021 Mar; 160(4):1164-1178.e6. PubMed ID: 33058866
[TBL] [Abstract][Full Text] [Related]
11. A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk.
Lu Y; Beeghly-Fadiel A; Wu L; Guo X; Li B; Schildkraut JM; Im HK; Chen YA; Permuth JB; Reid BM; Teer JK; Moysich KB; Andrulis IL; Anton-Culver H; Arun BK; Bandera EV; Barkardottir RB; Barnes DR; Benitez J; Bjorge L; Brenton J; Butzow R; Caldes T; Caligo MA; Campbell I; Chang-Claude J; Claes KBM; Couch FJ; Cramer DW; Daly MB; deFazio A; Dennis J; Diez O; Domchek SM; Dörk T; Easton DF; Eccles DM; Fasching PA; Fortner RT; Fountzilas G; Friedman E; Ganz PA; Garber J; Giles GG; Godwin AK; Goldgar DE; Goodman MT; Greene MH; Gronwald J; Hamann U; Heitz F; Hildebrandt MAT; Høgdall CK; Hollestelle A; Hulick PJ; Huntsman DG; Imyanitov EN; Isaacs C; Jakubowska A; James P; Karlan BY; Kelemen LE; Kiemeney LA; Kjaer SK; Kwong A; Le ND; Leslie G; Lesueur F; Levine DA; Mattiello A; May T; McGuffog L; McNeish IA; Merritt MA; Modugno F; Montagna M; Neuhausen SL; Nevanlinna H; Nielsen FC; Nikitina-Zake L; Nussbaum RL; Offit K; Olah E; Olopade OI; Olson SH; Olsson H; Osorio A; Park SK; Parsons MT; Peeters PHM; Pejovic T; Peterlongo P; Phelan CM; Pujana MA; Ramus SJ; Rennert G; Risch H; Rodriguez GC; Rodríguez-Antona C; Romieu I; Rookus MA; Rossing MA; Rzepecka IK; Sandler DP; Schmutzler RK; Setiawan VW; Sharma P; Sieh W; Simard J; Singer CF; Song H; Southey MC; Spurdle AB; Sutphen R; Swerdlow AJ; Teixeira MR; Teo SH; Thomassen M; Tischkowitz M; Toland AE; Trichopoulou A; Tung N; Tworoger SS; van Rensburg EJ; Vanderstichele A; Vega A; Edwards DV; Webb PM; Weitzel JN; Wentzensen N; White E; Wolk A; Wu AH; Yannoukakos D; Zorn KK; Gayther SA; Antoniou AC; Berchuck A; Goode EL; Chenevix-Trench G; Sellers TA; Pharoah PDP; Zheng W; Long J
Cancer Res; 2018 Sep; 78(18):5419-5430. PubMed ID: 30054336
[TBL] [Abstract][Full Text] [Related]
12. A rare variant in EZH2 is associated with prostate cancer risk.
Raspin K; FitzGerald LM; Marthick JR; Field MA; Malley RC; Banks A; Donovan S; Thomson RJ; Foley GR; Stanford JL; Dickinson JL
Int J Cancer; 2021 Sep; 149(5):1089-1099. PubMed ID: 33821477
[TBL] [Abstract][Full Text] [Related]
13. Epigenome-wide DNA methylation and transcriptome profiling of localized and locally advanced prostate cancer: Uncovering new molecular markers.
Liu Q; Reed M; Zhu H; Cheng Y; Almeida J; Fruhbeck G; Ribeiro R; Hu P
Genomics; 2022 Sep; 114(5):110474. PubMed ID: 36057424
[TBL] [Abstract][Full Text] [Related]
14. Epigenomic profiling of DNA methylation in paired prostate cancer versus adjacent benign tissue.
Geybels MS; Zhao S; Wong CJ; Bibikova M; Klotzle B; Wu M; Ostrander EA; Fan JB; Feng Z; Stanford JL
Prostate; 2015 Dec; 75(16):1941-50. PubMed ID: 26383847
[TBL] [Abstract][Full Text] [Related]
15. Transcriptome-wide association study of multiple myeloma identifies candidate susceptibility genes.
Went M; Kinnersley B; Sud A; Johnson DC; Weinhold N; Försti A; van Duin M; Orlando G; Mitchell JS; Kuiper R; Walker BA; Gregory WM; Hoffmann P; Jackson GH; Nöthen MM; da Silva Filho MI; Thomsen H; Broyl A; Davies FE; Thorsteinsdottir U; Hansson M; Kaiser M; Sonneveld P; Goldschmidt H; Stefansson K; Hemminki K; Nilsson B; Morgan GJ; Houlston RS
Hum Genomics; 2019 Aug; 13(1):37. PubMed ID: 31429796
[TBL] [Abstract][Full Text] [Related]
16. A Splicing Transcriptome-Wide Association Study Identifies Candidate Altered Splicing for Prostate Cancer Risk.
Sun Y; Bae YE; Zhu J; Zhang Z; Zhong H; Cheng C; Deng Y; Wu C; Wu L
OMICS; 2023 Aug; 27(8):372-380. PubMed ID: 37486714
[TBL] [Abstract][Full Text] [Related]
17. Influence of tissue context on gene prioritization for predicted transcriptome-wide association studies.
Li B; Veturi Y; Bradford Y; Verma SS; Verma A; Lucas AM; Haas DW; Ritchie MD
Pac Symp Biocomput; 2019; 24():296-307. PubMed ID: 30864331
[TBL] [Abstract][Full Text] [Related]
18. Transcriptome-Wide Association Study for Inflammatory Bowel Disease Reveals Novel Candidate Susceptibility Genes in Specific Colon Subsites and Tissue Categories.
Díez-Obrero V; Moratalla-Navarro F; Ibáñez-Sanz G; Guardiola J; Rodríguez-Moranta F; Obón-Santacana M; Díez-Villanueva A; Dampier CH; Devall M; Carreras-Torres R; Casey G; Moreno V
J Crohns Colitis; 2022 Feb; 16(2):275-285. PubMed ID: 34286847
[TBL] [Abstract][Full Text] [Related]
19. Genetically Predicted Levels of DNA Methylation Biomarkers and Breast Cancer Risk: Data From 228 951 Women of European Descent.
Yang Y; Wu L; Shu XO; Cai Q; Shu X; Li B; Guo X; Ye F; Michailidou K; Bolla MK; Wang Q; Dennis J; Andrulis IL; Brenner H; Chenevix-Trench G; Campa D; Castelao JE; Gago-Dominguez M; Dörk T; Hollestelle A; Lophatananon A; Muir K; Neuhausen SL; Olsson H; Sandler DP; Simard J; Kraft P; Pharoah PDP; Easton DF; Zheng W; Long J
J Natl Cancer Inst; 2020 Mar; 112(3):295-304. PubMed ID: 31143935
[TBL] [Abstract][Full Text] [Related]
20. Exploring targets of TET2-mediated methylation reprogramming as potential discriminators of prostate cancer progression.
Kamdar S; Isserlin R; Van der Kwast T; Zlotta AR; Bader GD; Fleshner NE; Bapat B
Clin Epigenetics; 2019 Mar; 11(1):54. PubMed ID: 30917865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
